Review Article
Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects
Table 2
Representative studies on the protective effects of N-acetylcysteine against various oxidative insults in the oral cavity.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALP: alkaline phosphatase; ATM: ataxia-telangiectasia mutated; CAT: catalase; Chk2: checkpoint kinase 2; Co: cobalt; COX-2: cyclooxygenase-2; CQ; camphorquinone; Cr: chromium; DSPP: dentin sialophosphoprotein; DMAE-CB: methacryloxylethyl cetyl ammonium chloride; ERK: extracellular signal-regulated kinase; GADD45α: growth arrest and DNA damage-inducible protein GADD45 alpha; GCL: γ-glutamylcysteine lygase; (GPx: glutathione peroxidase; GR: glutathione reductase; GSH: reduced glutathione; GSSG: oxidized form of glutathione; GST: glutathione S-transferase; HEMA: 2-hydroxyethyl methacrylate; HO-1: heme oxygenase 1; H2O2: hydrogen peroxide; IL-1β: interleukin-1beta; iNOS: inducible nitric oxide synthetase; JNK: c-Jun N-terminal kinase; LDH: lactate dehydrogenase; LPS: lipopolysaccharide; MDA: malondialdehyde; MMA: methyl methacrylate; MMP: matrix metalloproteinase; MTA: mineral trioxide aggregate; NAC: N-acetylcysteine; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; NO: nitric oxide; NQO: nitroquinoline 1-oxide; Nrf2: NF-E2-related factor 2; OCN: osteocalcin; PGE2: prostaglandin E2; p21: cyclin-dependent kinase inhibitor 1; p38 MAPK: p38 mitogen-activated protein kinase; P4H: prolyl-4 hydroxylase; p-JAK2: phosphorylation of janus kinase 2; ROS: reactive oxygen species; SOD: superoxide dismutase; STAT3: signal transducer and activator of transcription 3; TAS: total antioxidant status; TEGDMA: triethylenglycol dimethacrylate; TNF-α: tumor necrosis factor-alpha. |